Dihydroartemisinin enhances doxorubicin-induced apoptosis of triple negative breast cancer cells by negatively regulating the STAT3/HIF-1α pathway

doi:10.12122/j.issn.1673-4254.2025.02.06

Abstract

Abstract:

Objective To investigate the effects of dihydroartemisinin (DHA) combined with doxorubicin (DOX) on proliferation and apoptosis of triple-negative breast cancer cells and explore the underlying molecular mechanism. Methods MDA-MB-231 cells were treated with 50, 100 or 150 μmol/L DHA, 0.5 μmol/L DOX, or with 50 μmol/L DHA combined with 0.5 μmol/L DOX. The changes in proliferation and survival of the treated cells were examined with MTT assay and colony-forming assay, and cell apoptosis was analyzed with flow cytometry. Western blotting was performed to detect the changes in protein expression levels of PCNA, cleaved PARP, Bcl-2, Bax, STAT3, p-STAT3, HIF-1α and survivin. Results The IC₅₀ of DHA was 131.37±29.87 μmol/L in MDA-MB-231 cells. The cells with the combined treatment with DHA and DOX showed significant suppression of cell proliferation. Treatment with DHA alone induced apoptosis of MDA-MB-231 cells in a dose-dependent manner, but the combined treatment produced a much stronger apoptosis-inducing effect than both DHA and DOX alone. DHA at 150 μmol/L significantly inhibited clone formation of MDA-MB-231 cells, markedly reduced cellular expression levels of PCNA, p-STAT3, HIF-1α and survivin proteins, and obviously increased the expression level of cleaved PARP protein and the Bax/Bcl-2 ratio, and the combined treatment further reduced the expression level of p-STAT3 protein and increased the Bax/Bcl-2 ratio. Conclusion DHA combined with DOX produces significantly enhanced effects for inhibiting cell proliferation and inducing apoptosis in MDA-MB-231 cells possibly as result of DHA-mediated negative regulation of the STAT3/HIF-1α pathway.

Key words: dihydroartemisinin, doxorubicin, STAT3, HIF-1α, triple-negative breast cancer, apoptosis

Di CHEN, Ying LÜ, Yixin GUO, Yirong ZHANG, Ruixuan WANG, Xiaoruo ZHOU, Yuxin CHEN, Xiaohui WU. Dihydroartemisinin enhances doxorubicin-induced apoptosis of triple negative breast cancer cells by negatively regulating the STAT3/HIF-1α pathway[J]. Journal of Southern Medical University, 2025, 45(2): 254-260.

Figures/Tables 8

Fig.1 Effect of dihydroartemisinin (DHA) on proliferation of MDA-MB-231 cells (Mean±SD, n=3).

Fig.2 Effect of DHA on colony formation ability of MDA-MB-231 cells (Mean±SD, n=3). A: Colony-forming assay of the cells. B: Quantitative analysis of the results. **P<0.01 vs 0 μmol/L DHA.

Fig.3 Effect of DHA on apoptosis of MDA-MB-231 cells (Mean±SD, n=3). A: Flow cytometric analysis of cell apoptosis. B: Quantitative analysis of cell apoptosis. **P<0.01, ***P<0.001 vs 0 μmol/L DHA.

Fig.4 Effect of DHA on apoptosis-related protein expressions in MDA-MB-231 cells (Mean±SD, n=3). A: Protein bands in Western blotting. B: Protein expression levels. **P<0.01, ***P<0.001 vs 0 μmol/L DHA.

Fig.5 Effect of DHA on STAT3/HIF-1α signaling pathway protein expressions in MDA-MB-231 cells (Mean±SD, n=3). A: Protein bands in Western blotting. B: Protein expression levels. **P<0.01, ***P<0.001 vs 0 μmol/L DHA.

Fig.6 Effect of DHA combined with DOX on proliferation of MDA-MB-231 cells (Mean±SD, n=3). **P<0.01, ***P<0.001 vs DHA or DOX.

Fig.7 Effect of DHA combined with DOX on apoptosis of MDA-MB-231 cells (Mean±SD, n=3). A: Flow cytometric analysis of cell apoptosis. B: Quantitative analysis of cell apoptosis. ***P<0.01 vs DOX or DHA.

Fig.8 Effect of DHA and DOX on STAT3/HIF-1α signaling pathway protein expressions in MDA-MB-231 cells (Mean±SD, n=3). A: Protein bands in Western blotting. B: Protein expression levels. *P<0.05,**P<0.01, ***P<0.001 vs Control or DOX.

References 31

1	Loibl S, Poortmans P, Morrow M, et al. Breast cancer[J]. The Lancet, 2021, 8, 397(10286): 1750-69.
2	Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer[J]. Annu Rev Pathol, 2022, 24, 17: 181-204.
3	汪立刚, 文原梅, 周亮. 三阴性乳腺癌用药进展[J]. 中国现代应用药学, 2022, 39(11): 1509-16.
4	杨韬, 封龙飞, 郭欢, 等. 双氢青蒿素通过自噬作用抗肿瘤的研究现状[J]. 中国临床药理学杂志, 2023, 39(15): 2271-5.
5	从小凡, 陈腾, 李硕, 等. 双氢青蒿素通过促进活性氧的产生增强鼻咽癌细胞对顺铂诱导凋亡的敏感性[J]. 南方医科大学学报, 2024, 44(8): 1553-60.
6	张莉, 周丽, 唐艳, 等. 吴茱萸碱对子宫内膜癌细胞EMT及JAK/STAT3/HIF-1α通路的影响[J]. 世界科学技术-中医药现代化, 2022, 24(9): 3516-23.
7	高硕, 王金花. STAT3信号通路在三阴性乳腺癌中的研究进展[J]. 中国细胞生物学学报, 2020, 42(12): 2266-73.
8	McGettrick AF, O'Neill LAJ. The role of HIF in immunity and inflammation[J]. Cell Metab, 2020, 6, 32(4): 524-36.
9	Xu WQ, Zhuang LH, Zhu HX, et al. TRIM14 overexpression induces chemoresistance and malignant behaviors of hepatocellular carcinoma cells by activating the STAT3/HIF-1α pathway[J]. Int J Mol Sci, 2023, 9, 24(16): 12589.
10	Joshi N, Hajizadeh F, Ansari Dezfouli E, et al. Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression[J]. Life Sci, 2021, 275(15): 119369.
11	蔡雪婷, 杨杰, 胡春萍, 等. 双氢青蒿素通过抑制STAT3增加非小细胞肺癌细胞对吉非替尼的敏感性[J]. 科学通报, 2017, 62(18):2013-19.
12	Zhang J, Li Y, Wang JG, et al. Dihydroartemisinin affects STAT3/DDA1 signaling pathway and reverses breast cancer resistance to cisplatin[J]. Am J Chin Med, 2023, 51(2): 445-59.
13	Søgaard CK, Otterlei M. Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy[J]. Adv Pharmacol, 2024, 100: 209-46.
14	Mashimo M, Onishi M, Uno A, et al. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis[J]. J Biol Chem, 2021, 296: 100046.
15	Flanagan L, Lindner AU, de Chaumont C, et al. BCL-2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer[J]. J Mol Med (Berl), 2015, 93(3): 315-26.
16	Moldoveanu T, Follis AV, Kriwacki RW, et al. Metazoans and intrinsic apoptosis: an evolutionary analysis of the Bcl-2 family[J]. Int J Mol Sci, 2022, 28, 23(7): 3691.
17	Al-Zubaidy HFS, Majeed SR, Al-Koofee DAF. Evaluation of Bax and BCL 2 genes polymorphisms in Iraqi women with breast cancer[J]. Arch Razi Inst, 2022, 77(2): 799-808.
18	刘艳艳, 安倩, 海波, 等. 双氢青蒿素联合顺铂对人神经母细胞瘤细胞增殖及凋亡的影响[J]. 现代肿瘤医学, 2023, 31(22): 4129-35.
19	Yang W, Wei X, Jiao Y, et al. STAT3/HIF-1α/fascin-1 axis promotes RA FLSs migration and invasion ability under hypoxia[J]. Mol Immunol, 2021, 142(12): 83-94.
20	Veronica MR, Patricia MS, Dah YB, et al. Bone marrow macrophages induce inflammation by efferocytosis of apoptotic prostate cancer cells via HIF-1α stabilization[J]. Cells, 2022, 22, 11(23): 3712.
21	He HQ, Yi L, Zhang B, et al. USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway[J]. Int J Biol Sci, 2021, 11, 17(10): 2417-29.
22	Hasegawa K, Fujii S, Matsumoto S, et al. YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation[J]. J Pathol, 2021, 253(1): 80-93.
23	Yu TJ, Liu YY, Li XG, et al. PDSS1-mediated activation of CAMK2A-STAT3 signaling promotes metastasis in triple-negative breast cancer[J]. Cancer Res, 2021, 1, 81(21): 5491-505.
24	戴素华, 嵇晓艳, 戴夕超. GSTP1通过调控STAT3信号通路促进乳腺癌细胞增殖与阿霉素耐药[J]. 临床肿瘤学杂志, 2024, 29(2):114-9.
25	Cavalcante RS, Ishikawa U, Silva ES, et al. STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomo-dulatory therapy in breast cancer[J]. Br J Pharmacol, 2021, 178(11): 2284-304.
26	Infantino V, Santarsiero A, Convertini P, et al. Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic Target[J]. Int J Mol Sci, 2021, 22(11): 5703.
27	Mirzaei S, Gholami MH, Hashemi F, et al. Advances in understanding the role of P-gp in doxorubicin resistance: molecular pathways, therapeutic strategies, and prospects[J]. Drug Discov Today, 2022, 27(2): 436-55.
28	Wang XH, Wei LL, Li QC, et al. HIF-1α protects osteoblasts from ROS-induced apoptosis[J]. Free Radic Res, 2022, 56(2):143-53.
29	Dong SH, Liang S, Cheng ZQ, et al. ROS/PI3K/Akt and Wnt/ β‑catenin signalings activate HIF-1α‑induced metabolic repro-gramming to impart 5-fluorouracil resistance in colorectal cancer[J]. J Exp Clin Cancer Res, 2022, 8, 41(1): 15.
30	Chen ZZ, Liu ZH, Zhang Q, et al. Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance[J]. Front Pharmacol, 2023, 24, 14: 1133011.
31	Liu Q, Guan CC, Liu C, et al. Targeting hypoxia-inducible factor-1alpha: a new strategy for triple-negative breast cancer therapy[J]. Biomed Pharmacother, 2022, 156: 113861.

[1]	Qiaoyan CAI, Yaoyao XU, Yuxing LIN, Haowei LIN, Junpeng ZHENG, Weixiang ZHANG, Chunyu ZHAO, Yupeng LIN, Ling ZHANG. Qingda Granules alleviate brain damage in spontaneously hypertensive rats by modulating the miR-124/STAT3 signaling axis [J]. Journal of Southern Medical University, 2025, 45(1): 18-26.
[2]	Hui ZHANG, Yangyang LIU, Xiapeng LI, Mengyao WANG, Li LI, Haitao WEI. High KHSRP expression promotes gastric adenocarcinoma metastasis: the mediating role of the JAK1/STAT3 signaling axis [J]. Journal of Southern Medical University, 2024, 44(9): 1760-1768.
[3]	Shuo LIU, Jing LI, Xingwang WU. Swertiamarin ameliorates 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice by inhibiting intestinal epithelial cell apoptosis [J]. Journal of Southern Medical University, 2024, 44(8): 1545-1552.
[4]	Xiaofan CONG, Teng CHEN, Shuo LI, Yuanyuan WANG, Longyun ZHOU, Xiaolong LI, Pei ZHANG, Xiaojin SUN, Surong ZHAO. Dihydroartemisinin enhances sensitivity of nasopharyngeal carcinoma HNE1/DDP cells to cisplatin-induced apoptosis by promoting ROS production [J]. Journal of Southern Medical University, 2024, 44(8): 1553-1560.
[5]	Yuming ZHANG, Shicheng XIA, Linlin ZHANG, Mengxi CHEN, Xiaojing LIU, Qin GAO, Hongwei YE. Protective effect of Lonicerae japonicae flos extract against doxorubicin-induced liver injury in mice [J]. Journal of Southern Medical University, 2024, 44(8): 1571-1581.
[6]	Linyu XIAO, Ting DUAN, Yongsheng XIA, Yue CHEN, Yang SUN, Yibo XU, Lei XU, Xingzhou YAN, Jianguo HU. Linarin inhibits microglia activation-mediated neuroinflammation and neuronal apoptosis in mouse spinal cord injury by inhibiting the TLR4/NF-κB pathway [J]. Journal of Southern Medical University, 2024, 44(8): 1589-1598.
[7]	Mengdong ZHENG, Yan LIU, Jiaojiao LIU, Qiaozhen KANG, Ting WANG. Effect of deletion of protein 4.1R on proliferation, apoptosis and glycolysis of hepatocyte HL-7702 cells [J]. Journal of Southern Medical University, 2024, 44(7): 1355-1360.
[8]	Yuanguo WANG, Peng ZHANG. Ferroptosis suppressor genes are highly expressed in esophageal cancer to inhibit tumor cell ferroptosis [J]. Journal of Southern Medical University, 2024, 44(7): 1389-1396.
[9]	Zhijun REN, Jianxin DIAO, Yiting WANG. Xionggui Decoction alleviates heart failure in mice with myocardial infarction by inhibiting oxidative stress-induced cardiomyocyte apoptosis [J]. Journal of Southern Medical University, 2024, 44(7): 1416-1424.
[10]	Guiling CHEN, Xiaofeng LIAO, Pengtao SUN, Huan CEN, Shengchun SHU, Bijing LI, Jinhua LI. Solasonine promotes apoptosis of non-small cell lung cancer cells by regulating the Bcl-2/Bax/caspase-3 pathway [J]. Journal of Southern Medical University, 2024, 44(6): 1109-1116.
[11]	Lingjun LU, Xiaodi YANG, Huaping ZHANG, Yuan LIANG, Xiulan SHI, Xin ZHOU. Recombinant Schistosoma japonicum cystatin alleviates acute liver injury in mice by inhibiting endoplasmic reticulum stress, inflammation and hepatocyte apoptosis [J]. Journal of Southern Medical University, 2024, 44(6): 1126-1134.
[12]	Guoxin LIANG, Hongyue TANG, Chang GUO, Mingming ZHANG. MiR-224-5p overexpression inhibits oxidative stress by regulating the PI3K/Akt/FoxO1 axis to attenuate hypoxia/reoxygenation-induced cardiomyocyte injury [J]. Journal of Southern Medical University, 2024, 44(6): 1173-1181.
[13]	HE Cheng, CHEN Wei, ZHANG Nianzhi, LUAN Jun, WANG Sanfeng, ZHANG You. Shenqi Chongcao Formula ameliorates inflammatory response in rats with pulmonary fibrosis by activating the ASS1/src/STAT3 signaling pathway [J]. Journal of Southern Medical University, 2024, 44(4): 644-651.
[14]	XI Jin, ZHANG Min, ZHANG Yongyu, ZHANG Chen, ZHANG Yulu, WANG Rui, SHEN Lin, LI Jing, SONG Xue. Upregulating KLF11 ameliorates intestinal inflammation in mice with 2, 4, 6-trinitrobenesulfonic acid-induced colitis by inhibiting the JAK2/STAT3 signaling pathway [J]. Journal of Southern Medical University, 2024, 44(4): 765-772.
[15]	ZHANG Feng, FAN Linlin, KANG Xia, WEI Haitao, LI Li. High LINC00626 expression promotes esophagogastric junction adenocarcinoma metastasis: the mediating role of the JAK1/STAT3/KHSRP axis [J]. Journal of Southern Medical University, 2024, 44(3): 541-552.